Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2021-08-03 00:00:00 ET · period of report 2021-07-30 · accession 0001214659-21-008125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-03 | 2021-07-30 | ALLO | SATO VICKI L | Dir | A - Grant | $0.00 | +19.4K | 19.4K | New | $0 |
| D | 2021-08-03 | 2021-07-30 | ALLO | SATO VICKI L | Dir | A - Grant | $0.00 | +31.7K | 31.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-30 | A | A | 19,362 | $0.00 | 19,362 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-07-30 | A | A | 31,692 | $0.00 | 31,692 | D | $21.95 · — to 2031-07-30 | 31,692 Common Stock | (F1) The shares subject to the stock option shall vest in a series of 36 successive equal monthly installments measured from the date of grant. |